JOSEPH P. DOUGHERTY, a Vice President at Lehman Brothers, joined the
firm in April 2000 from UBS Warburg, where he was Senior Biotechnology
Analyst. He was at UBSW and its predecessor firms for three years. Prior
to coming to the Street, he was a scientist at Gilead Sciences in
antiviral and cardiovascular medicinal chemistry and drug development,
and at Genetics Institute in DNA-based diagnostics and bioorganic
chemistry. He has an AB in Chemistry from Harvard, a PhD in Bioorganic
Chemistry from Columbia, and is the author of numerous scientific papers
and several patents.
Roundtable Forum: Biotechnology
July 08, 2002